Jaime M. Pita
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Journal: Frontiers in endocrinology
Published: June 26, 2023
Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy.
Journal: Current opinion in oncology
Published: November 18, 2022
Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27.
Journal: Cell cycle (Georgetown, Tex.)
Published: December 16, 2021
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib.
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib.
Journal: EMBO molecular medicine
Published: June 02, 2017
JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21.
Journal: Oncogene
Published: August 19, 2016
Cheese-related listeriosis outbreak, Portugal, March 2009 to February 2012.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: May 09, 2015
Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 16, 2014
Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence".
Journal: Cancer metastasis reviews
Published: April 26, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026